The U.S. patient positioning and support aids market size was exhibited at USD 514.15 million in 2024 and is projected to hit around USD 1045.96 million by 2034, growing at a CAGR of 7.36% during the forecast period 2025 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 551.99 Million |
Market Size by 2034 | USD 1045.96 Million |
Growth Rate From 2025 to 2034 | CAGR of 7.36% |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Segments Covered | Product, End-use |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Key Companies Profiled | Spry; Medline Industries, LP; Arjo; EHOB; DeRoyal Industries, Inc.; Etac AB; Hillrom (Baxter); Guldmann; ANSELL LTD; Mölnlycke Health Care AB; Stryker; Soule Medical; STERIS; Cardinal Health |
The increasing volume of surgical procedures, the elderly population, and advancements in healthcare infrastructure are some of the key factors driving the market growth. As the aging population rises, the prevalence of chronic diseases and conditions requiring surgical interventions, such as joint replacements and cardiovascular procedures, also increases. This drives demand for effective patient positioning and support aids to ensure safety, comfort, and optimal access during procedures.
Cardiovascular diseases (CVD) significantly drive the U.S. patient positioning and support aids market growth due to their high prevalence and the critical need for precise patient handling during diagnostic and therapeutic interventions. CVD remains a leading cause of morbidity and mortality in the U.S., leading to a substantial number of surgical procedures, including angioplasties, bypass surgeries, and heart valve replacements. These procedures often require specialized positioning aids to ensure patient safety, enhance surgical accuracy, and improve outcomes.
Diagnostic tests such as echocardiograms, cardiac catheterizations, and imaging studies such as CT and MRI scans rely on effective patient positioning to provide precise, accurate results. The increasing adoption of minimally invasive techniques and robotic-assisted surgeries in cardiology further boosted the need for advanced positioning aids designed for precision and stability. Moreover, the aging population, which is more susceptible to CVD, contributes to a rising demand for these aids in hospital and ambulatory care settings. The focus on reducing pressure injuries, optimizing comfort, and adhering to stringent safety standards further supports the growth of this market segment. According to the American Health Association, in 2024, there were 931,578 cardiovascular disease deaths in the U.S. This was an increase of less than 3,000 from the previous year. The age-adjusted death rate for CVD in 2024 was 233.3 per 100,000, which was a 4.0% increase from 2023.
The increasing number of surgical procedures is expected to boost the demand for patient positioning and support aids in the U.S. The surgeries require positioning and support aids such as fluidized positioners, gel positioners, pillows, wedges, transfer aids, repositioning products, turning systems, slide sheets, and offloading devices to prevent the patient from pressure ulcers and to move the patient from one area to another area post-surgical procedures. Various surgical procedures, such as orthopedic, neurosurgeries, and cosmetic surgeries, are being carried out. For instance, as per a study published by the National Library of Medicine in July 2020, around 310 million major surgical procedures are performed annually, of which around 40 to 50 million are conducted in the U.S.
Hospital admissions are a key growth driver for the U.S. patient positioning and support aids industry, as these aids are integral to providing safe, effective, and comfortable care for patients during their hospital stays. High admission rates, mainly for conditions requiring extended care, critical interventions, and rehabilitation, directly increase the demand for such products. As per the American Hospital Association, 2022, the total number of hospital admissions in the U.S. exceeds 33 million annually. Large-scale procurement of positioning aids, such as hospital beds, mattresses, and cushions, becomes essential for hospitals to meet patient care demands.
The gel and foam positioners segment dominated the market in 2024 and is expected to register a significant CAGR from 2025 to 2034. The growth is driven by the rising prevalence of pressure injuries, particularly among immobile patients and those recovering from surgical procedures. Gel and foam positioners are designed to distribute weight evenly, reducing pressure points and enhancing patient comfort during extended periods of immobility. Advancements in technology also contribute to the growth of this segment.
Manufacturers are constantly innovating their products, incorporating advanced materials that enhance the performance of gel and foam positioners. These materials provide better pressure redistribution, temperature regulation, and moisture management, crucial for maintaining skin integrity and patient comfort. For instance, in August 2023, U.S. Surgitech, Inc., one of the prominent medical device manufacturers, announced that it had been granted a patent for its innovative SurgyPad patient positioning system. The SurgyPad is an advanced patient positioning system that improves safety and comfort during surgical procedures. Its innovative design features integrated arm protectors, an anti-skid strip along the back, and additional safety straps to ensure exceptional patient security. Made with moisture-absorbing, high-rebound foam, the SurgyPad offers optimal support and pressure distribution while helping to minimize the risk of post-operative complications.
The fluidized positioners segment is anticipated to grow the fastest over the forecast period. The adaptability of fluidized positioners enhances their usability across various clinical environments, including surgical theaters, intensive care units, and long-term care facilities. They aid in multiple procedures, such as surgeries and diagnostic imaging, where precise positioning is crucial for patient safety and procedural efficacy. One of the primary driving factors is the growing prevalence and incidence of pressure ulcers. For instance, according to the Agency for Healthcare Research and Quality, more than 2.5 million individuals in the U.S. develop pressure ulcers annually. These conditions continue to be prevalent across all age groups and settings following surgery.
The hospital end use segment dominated the market in 2024. The growth of the hospital segment in the patient positioning and support aids market can be attributed to the increasing prevalence of chronic diseases, which has led to a surge in surgical interventions. Procedures such as orthopedic surgeries, cardiothoracic surgeries, and laparoscopic surgeries contribute significantly to the demand for effective patient positioning solutions. Hospitals are investing in ergonomic and innovative positioning systems to optimize surgical outcomes and enhance patient safety.
The rehabilitation center segment is anticipated to grow the fastest over the forecast period. The rising incidence of disabilities results from various factors, including aging populations, obesity, and chronic conditions such as stroke and arthritis. As the number of patients requiring rehabilitative services continues to increase, the demand for effective patient positioning aids has also grown. These aids enhance patients’ comfort during rehabilitation sessions and facilitate better therapist access, promoting efficient therapeutic practices. Technological advancements have further transformed the landscape of patient positioning aids used in rehabilitation centers. Innovations in materials and ergonomic design have led to the development of more versatile and adjustable devices, capable of accommodating a wide range of patient needs.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. patient positioning and support aids market
By Product
By End-use
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Patient Positioning and Support Aids Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Burden of Hospital-Acquired Infections
3.2.1.2. Growing Prevalence of Chronic And Lifestyle Associated Diseases
3.2.1.3. Rising Awareness About Patient Safety
3.2.1.4. Innovations in Medical Technology
3.2.1.5. Increasing Number of Surgical Procedures
3.2.2. Market Restraint Analysis
3.2.2.1. Product recalls
3.2.2.2. High cost associated with equipment
3.2.3. Market Opportunities Analysis
3.2.4. Market Challenge Analysis
3.3. U.S. Patient Positioning and Support Aids Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining Power Of Suppliers
3.3.1.2. Bargaining Power Of Buyers
3.3.1.3. Threat Of Substitutes
3.3.1.4. Threat Of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological Landscape
Chapter 4. U.S. Patient Positioning and Support Aids Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Patient Positioning and Support Aids Market Movement Analysis
4.3. U.S. Patient Positioning and Support Aids Market Size & Trend Analysis, by Product, 2021 to 2034 (USD Million)
4.4. Gel and foam positioners
4.4.1. Gel and Foam Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.4.2. Reusable Gel Positioners
4.4.2.1. Reusable Gel Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.4.3. Disposable Foam Positioners
4.4.3.1. Disposable Foam Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.5. Pillows and Wedges
4.5.1. Pillows and Wedges U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.5.2. Bed Wedge
4.5.2.1. Bed Wedge U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.5.3. Positioning Pillows
4.5.3.1. Positioning Pillows U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.6. Sling-Based Positioning Aids
4.6.1. Sling-Based Positioning Aids U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.7. Repositioning and Turning Systems
4.7.1. Repositioning and Turning Systems U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.8. Air-Assisted Transfer Aids
4.8.1. Air-Assisted Transfer Aids U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.9. Offloading Devices and Suspension Boots
4.9.1. Offloading Devices and Suspension Boots U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.10. Slide Sheets
4.10.1. Slide Sheets U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.11. Fluidized Positioners
4.11.1. Fluidized Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.11.2. Flo Fluidized Positioners
4.11.2.1. Flo Fluidized Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.11.3. Flo-Lock Filtered Positioners
4.11.3.1. Flo-Lock Filtered Positioners U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
4.12. Others
4.12.1. Others U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
Chapter 5. U.S. Patient Positioning and Support Aids Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Patient Positioning and Support Aids Market Movement Analysis
5.3. U.S. Patient Positioning and Support Aids Market Size & Trend Analysis, by End Use, 2021 to 2034 (USD Million)
5.4. Hospitals
5.4.1. Hospitals U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
5.5. Rehabilitation Centers
5.5.1. Rehabilitation Centers U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
5.6. Nursing Homes
5.6.1. Nursing Homes U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
5.7. Home Healthcare
5.7.1. Home Healthcare U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
5.8. Others
5.8.1. Others U.S. Patient Positioning and Support Aids Market Revenue Estimates and Forecasts, 2021 - 2034 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Strategy Mapping
6.3. Company Market Position Analysis, 2024
6.4. List of Key Certification Providers/Scheme Owners
6.5. Company Profiles/Listing
6.5.1. Spry
6.5.1.1. Company overview
6.5.1.2. Financial performance
6.5.1.3. Product Type benchmarking
6.5.1.4. Strategic initiatives
6.5.2. Medline Industries, LP
6.5.2.1. Company overview
6.5.2.2. Financial performance
6.5.2.3. Product Type benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Arjo
6.5.3.1. Company overview
6.5.3.2. Financial performance
6.5.3.3. Product Type benchmarking
6.5.3.4. Strategic initiatives
6.5.4. EHOB
6.5.4.1. Company overview
6.5.4.2. Financial performance
6.5.4.3. Product Type benchmarking
6.5.4.4. Strategic initiatives
6.5.5. DeRoyal Industries, Inc.
6.5.5.1. Company overview
6.5.5.2. Financial performance
6.5.5.3. Product Type benchmarking
6.5.5.4. Strategic initiatives
6.5.6. Etac AB
6.5.6.1. Company overview
6.5.6.2. Financial performance
6.5.6.3. Product Type benchmarking
6.5.6.4. Strategic initiatives
6.5.7. Hillrom (Baxter)
6.5.7.1. Company overview
6.5.7.2. Financial performance
6.5.7.3. Product Type benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Guldmann
6.5.8.1. Company overview
6.5.8.2. Financial performance
6.5.8.3. Product Type benchmarking
6.5.8.4. Strategic initiatives
6.5.9. ANSELL LTD
6.5.9.1. Company overview
6.5.9.2. Financial performance
6.5.9.3. Product Type benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Mölnlycke Health Care AB
6.5.10.1. Company overview
6.5.10.2. Financial performance
6.5.10.3. Product Type benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Stryker
6.5.11.1. Company overview
6.5.11.2. Financial performance
6.5.11.3. Product Type benchmarking
6.5.11.4. Strategic initiatives
6.5.12. Soule Medical
6.5.12.1. Company overview
6.5.12.2. Financial performance
6.5.12.3. Product Type benchmarking
6.5.12.4. Strategic initiatives
6.5.13. STERIS
6.5.13.1. Company overview
6.5.13.2. Financial performance
6.5.13.3. Product Type benchmarking
6.5.13.4. Strategic initiatives
6.5.14. Cardinal Health
6.5.14.1. Company overview
6.5.14.2. Financial performance
6.5.14.3. Product Type benchmarking
6.5.14.4. Strategic initiatives